Share this article:

Allergan PLC will “double down on brands” in the wake of a deal to sell off its generic lines—a move that pushes the drugmaker’s Irvine operation further into the spotlight...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99

For digital licensing requests for this article, Contact Kim Lopez